NO954767L - 4-amino-17 delser som C17-20-lyase- og 5 - Google Patents

4-amino-17 delser som C17-20-lyase- og 5

Info

Publication number
NO954767L
NO954767L NO954767A NO954767A NO954767L NO 954767 L NO954767 L NO 954767L NO 954767 A NO954767 A NO 954767A NO 954767 A NO954767 A NO 954767A NO 954767 L NO954767 L NO 954767L
Authority
NO
Norway
Prior art keywords
compounds
amino
lyase
androst
prepared
Prior art date
Application number
NO954767A
Other languages
English (en)
Norwegian (no)
Other versions
NO954767D0 (no
Inventor
Philip Marvin Weintraub
Cynthia Gates
Michael Angelastro
J O'neal Johnston
Timothy T Curran
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO954767D0 publication Critical patent/NO954767D0/no
Publication of NO954767L publication Critical patent/NO954767L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO954767A 1993-05-25 1995-11-24 4-amino-17 delser som C17-20-lyase- og 5 NO954767L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6674493A 1993-05-25 1993-05-25
US20950194A 1994-03-16 1994-03-16
US08/231,434 US5486511A (en) 1993-05-25 1994-05-02 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
PCT/US1994/005075 WO1994028010A1 (en) 1993-05-25 1994-05-06 4-AMINO-17β-(CYCLOPROPYLOXY)ANDROST-4-EN-3-ONE, 4-AMINO-17β-(CYCLOPROPYLAMINO)ANDROST-4-EN-3-ONE AND RELATED COMPOUNDS AS C17-20 LYASE AND 5α-REDUCTASE INHIBITORS

Publications (2)

Publication Number Publication Date
NO954767D0 NO954767D0 (no) 1995-11-24
NO954767L true NO954767L (no) 1996-01-25

Family

ID=27371031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954767A NO954767L (no) 1993-05-25 1995-11-24 4-amino-17 delser som C17-20-lyase- og 5

Country Status (11)

Country Link
US (1) US5486511A (ja)
EP (1) EP0700400A1 (ja)
JP (1) JPH08510733A (ja)
CN (1) CN1124490A (ja)
AU (1) AU674971B2 (ja)
CA (1) CA2161649A1 (ja)
FI (1) FI955642A7 (ja)
HU (1) HUT73239A (ja)
NO (1) NO954767L (ja)
NZ (1) NZ267231A (ja)
WO (1) WO1994028010A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
ES2178750T3 (es) * 1996-02-14 2003-01-01 Aventis Pharma Inc 17-beta- iclopropil(amino/oxi)4-aza esteroides como inhibidores activos de la 5-alfa-reductasa y de c17-20-liasa de testosterona.
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
DK0998930T3 (da) * 1997-07-29 2004-04-26 Sankyo Co Azasteroidforbindelser til behandling af alopecia, hirsutisme og seborrhea
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
CZ20013912A3 (cs) * 1999-05-04 2002-05-15 Strakan Limited Androgen glykosid, sloučenina, testosteron-ß-D-glukosid, 5 alfa-Dihydrotestosteron- 17ß-D-glukosid, farmaceutický prostředek a pouľití sloučeniny
CA2386190C (en) 1999-10-13 2009-04-14 Johns Hopkins University School Of Medicine Regulators of the hedgehog pathway, compositions and uses related thereto
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
JP2008500368A (ja) * 2004-05-27 2008-01-10 ミジェニックス コーポレイション 細胞保護のための２置換１７−イミノエストロゲン化合物
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法
EP2060261B1 (en) 2007-11-13 2016-03-09 Athenion AG C-19 steroids for cosmetic uses

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB204888A (en) * 1922-09-26 1923-10-11 William Gibson Flap support for clubs in golf bags
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
US3732209A (en) * 1971-03-15 1973-05-08 Hoffmann La Roche Novel 17beta-oxygenated cyclopropa(16alpha,17alpha)steroids
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives
DE3711772A1 (de) * 1987-04-08 1988-10-27 Schering Ag 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
NZ224288A (en) * 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
NZ239142A (en) * 1990-08-01 1994-05-26 Merrell Dow Pharma 4-amino-delta-4-steroids; preparatory processes and pharmaceutical compositions
US5318961A (en) * 1990-08-01 1994-06-07 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
AU642757B2 (en) * 1990-08-01 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
JPH06510982A (ja) * 1991-02-27 1994-12-08 ニューヨーク ユニバーシティ 抗テストステロン化合物およびその使用方法
US5189032A (en) * 1991-03-19 1993-02-23 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
US5218810A (en) * 1992-02-25 1993-06-15 Hexcel Corporation Fabric reinforced concrete columns

Also Published As

Publication number Publication date
WO1994028010A1 (en) 1994-12-08
FI955642A0 (fi) 1995-11-23
NO954767D0 (no) 1995-11-24
US5486511A (en) 1996-01-23
NZ267231A (en) 1997-05-26
AU6945594A (en) 1994-12-20
CA2161649A1 (en) 1994-12-08
CN1124490A (zh) 1996-06-12
HU9503369D0 (en) 1996-01-29
HUT73239A (en) 1996-07-29
AU674971B2 (en) 1997-01-16
JPH08510733A (ja) 1996-11-12
FI955642A7 (fi) 1995-11-23
EP0700400A1 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
Cole et al. Mechanism and inhibition of cytochrome P-450 aromatase
Rowlands et al. Esters of 3-pyridylacetic acid that combine potent inhibition of 17. alpha.-Hydroxylase/C17, 20-lyase (Cytochrome P45017. alpha.) with resistance to esterase hydrolysis
Brueggemeier Aromatase inhibitors—mechanisms of steroidal inhibitors
Potter et al. Novel steroidal inhibitors of human cytochrome P45017. alpha.-Hydroxylase-C17, 20-lyase): potential agents for the treatment of prostatic cancer
HRP921221A2 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives and process for r preparation
FI95804C (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 4-substituoituja 17 -(syklopropyyliamino)androst-5-eenijohdannaisia, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
áJohn Smith et al. Inhibitors of enzymes of androgen biosynthesis: cytochrome P450 17α and 5 α-steroid reductase
Fischer et al. Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity
Njar et al. 20-Amino and 20, 21-aziridinyl pregnene steroids: development of potent inhibitors of 17α-hydroxylase/C17, 20-lyase (P450 17)
WO2012129673A1 (en) INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
US5486511A (en) 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
DE68911157D1 (de) Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate.
US5527806A (en) 17α and 17β substituted acyl 4 aza steroids
Yadav et al. Steroidal carbonitriles as potential aromatase inhibitors
DE69507139T2 (de) Verfahren zur herstellung von 4-amino-delta 4-3-ketosteroiden via 4-nitro-delta-4-3-ketosteroiden
Bansal et al. Synthesis and biological evaluation of 16E-arylidenosteroids as cytotoxic and anti-aromatase agents
Auvray et al. MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase
US5561124A (en) 17-α-acyl steroids which inhibit 5-α-reductase
JPS61178920A (ja) ４−エン−１６，１６−ジ置換−３−オンステロイドを含有する医薬組成物
Numazawa et al. Structure–activity relationships of estrogen derivatives as aromatase inhibitors. Effects of heterocyclic substituents
WO1999006050A1 (en) Remedial agent for baldness and other diseases
Numazawa et al. 6α, 7 ga-Cyclopropane derivatives of androst-4-ene: A novel class of competitive aromatase inhibitors
Brueggemeier et al. A photoaffinity inhibitor of aromatase
Ebrahimian et al. Synthesis and biochemical studies of 7α-substituted androsta-1, 4-diene-3, 17-diones as enzyme-activated irreversible inhibitors of aromatase
US4810701A (en) 11-desoxy-17α-hydroxycorticosterone derivatives